News & Updates

Treatment with topical recombinant human nerve growth factor (rhNGF) is safe and well tolerated but falls short of providing neuroprotection in patients with glaucoma, according to the results of a phase Ib study.

Giving adjuvant S-1 to patients with curatively resected biliary tract cancer (BTC) significantly improves survival compared with observation following surgery, according to the ASCOT trial presented in the 2022 ASCO Gastrointestinal Cancers Symposium (GICS).

Ultrasound is a dependable tool for monitoring loss of muscle mass in recipients of allogeneic haemoatopoietic stem cell transplantation (allo-HSCT), a recent study has found.

Acupuncture seems to be better than pharmacotherapy at relieving emotional symptoms in patients with functional gastrointestinal disorders (FGIDs), reports a recent meta-analysis.

A rater-blind randomized trial conducted by the Chinese University of Hong Kong (CUHK) in collaboration with the Hong Kong Polytechnic University and BrainNow Research Institute in Shenzhen, China, has found that regular aerobic exercise led to pulse and blood pressure (BP) reductions as well as maintenance of global cognition in older people with moderate to severe subclinical cerebral small vessel disease (CSVD).